PlushCare vs Push Health
PlushCare costs $801 less a month, and both sell semaglutide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
PlushCare
Best for: coverage in all 50 states, which most sellers will not confirm
Visit PlushCare →
If you are choosing between PlushCare and Push Health, the first difference is cost: PlushCare is $801 a month cheaper at the entry price. Both prescribe semaglutide, so moving from one to the other would not change your drug. PlushCare leads our six-part score, 6.4 to 5.6.
PlushCare vs Push Health price
PlushCare is the cheaper way in: $149 a month against $950 a month at Push Health. That is $801 less each month (84% lower), or about $9,612 over a year of treatment.
Drug by drug: Semaglutide is cheaper at PlushCare ($149 a month vs $950 a month).
Medications and formats
Both sell semaglutide; only PlushCare lists tirzepatide.
On format, PlushCare prices compounded injections, while Push Health prices brand-name pens.
If you want the FDA-approved brand rather than a compounded version, Push Health is the only one of the two with a brand-name price.
Where each one treats patients
PlushCare lists 50 states, and Push Health does not publish where it ships.
Pricing
PlushCare
Range up to $299/mo
Range up to $599/mo
Push Health
Ozempic / brand
What each price covers
PlushCare is silent on shipping and coaching.
Push Health does not say what its price includes.
PlushCare
Covered by the monthly price
Medication
Charged on top
Clinician visits
Charged on top
Shipping
Not stated
Lab work
Charged on top
Coaching
Not stated
Push Health
Inclusions not disclosed.
Where each one scores higher
Overall, PlushCare scores 6.4 and Push Health 5.6 out of 10.
PlushCare is stronger on effectiveness (10.0 vs 9.0), user experience (7.0 vs 3.0), trust & safety (7.5 vs 4.0) and accessibility (10.0 vs 5.0).
Push Health is stronger on value (5.3 vs 3.0) and support (5.0 vs 0.0).
PlushCare
6.4/10
Push Health
5.6/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither PlushCare nor Push Health has an FDA warning letter on record with us.
Features & Coverage
| Feature | PlushCare | Push Health |
|---|---|---|
| Starting Price | ✓$149/mo | $950/mo |
| Features | ✓8 features | 5 features |
| States Available | 50 | Not disclosed |
| Compounded | ✓ Yes | — |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About PlushCare
PlushCare is an established virtual primary-care telehealth platform and a subsidiary of Transcarent, Inc., a Delaware corporation that also owns Accolade, 2nd.MD, and 98point6 by Transcarent. Virtual visits with US board-certified physicians cost $30 per appointment insured and $129 self-pay. GLP-1 prescribing is a clinician-discretionary option within the broader primary-care relationship.
Read our full PlushCare review →About Push Health
A 55,000+ pharmacy network sits behind Push Health, which writes brand-name GLP-1 prescriptions, Mounjaro, Zepbound, and Ozempic, and routes them through it. The platform is a large US telehealth operation and holds LegitScript certification.
Read our full Push Health review →Pros & Cons
PlushCare
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- Serves all 50 states
- We found no FDA warning letters issued to PlushCare
- A live video visit with a clinician is required before a prescription, which is slower than a form and is the more careful intake
- Baseline bloodwork is required before a prescription
Watch-outs
- Not included in the monthly price: medication, clinician visits, lab work
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Push Health
What we like
- Semaglutide costs $950 a month, close to the $990 median for brand-name semaglutide across the sellers we compare
- We found no FDA warning letters issued to Push Health
Watch-outs
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Our Verdict
PlushCare wins this one, 6.4 to 5.6, above all for coverage in all 50 states, which most sellers will not confirm. It also costs $801 less each month than Push Health. Push Health fits better if semaglutide from $950/month is your priority.
Choose PlushCare if…
You want coverage in all 50 states, which most sellers will not confirm and an opening price near $149 a month.
Choose Push Health if…
You want semaglutide from $950/month and an opening price near $950 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
HealthRX
Compounded semaglutide at $133/month
From $133/mo
Get started →RNK Health
An oral route if you will not self-inject
From $197/mo
Get started →He & She MD
Starting below a standard dose, with microdose tiers
From $99/mo
Get started →PlushCare vs Push Health: FAQ
Close alternatives to PlushCare and Push Health
- PlushCare vs altRX
- PlushCare vs Trinity Meds
- PlushCare vs Gala
- PlushCare vs Lttl
- Push Health vs JumpstartMD
- Push Health vs Marek Health
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.